MARKET

MRNA

MRNA

Moderna
NASDAQ
170.27
-2.98
-1.72%
Pre Market: 169.89 -0.38 -0.22% 06:01 02/07 EST
OPEN
171.98
PREV CLOSE
173.25
HIGH
174.41
LOW
169.67
VOLUME
932
TURNOVER
--
52 WEEK HIGH
217.25
52 WEEK LOW
115.03
MARKET CAP
65.41B
P/E (TTM)
6.16
1D
5D
1M
3M
1Y
5Y
Moderna Inc. stock underperforms Monday when compared to competitors
MarketWatch · 13h ago
Personalis extends winning streak as Needham upgrades
Seeking Alpha · 15h ago
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
Benzinga · 16h ago
Catalent Stock Surges on Report of Danaher Interest. M&A May Be Back.
Barron's · 23h ago
Catalent Stock Rockets 21% Premarket On Report Of Takeover Interest From Danaher -- MarketWatch
MarketWatch · 23h ago
FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet
Reuters · 1d ago
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In January: Where Do SPY, Tesla, Apple And Ford Rank?
Benzinga · 1d ago
The Clock Is Ticking For Seres Therapeutics: I'm Not Afraid
Seeking Alpha · 2d ago
More
About MRNA
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.

Webull offers kinds of Moderna Inc stock information, including NASDAQ:MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.